DK0952835T3 - Fremgangsmåde til behandling af hjertesygdom forårsaget af Chlamydia pneumoniae - Google Patents

Fremgangsmåde til behandling af hjertesygdom forårsaget af Chlamydia pneumoniae

Info

Publication number
DK0952835T3
DK0952835T3 DK97909440T DK97909440T DK0952835T3 DK 0952835 T3 DK0952835 T3 DK 0952835T3 DK 97909440 T DK97909440 T DK 97909440T DK 97909440 T DK97909440 T DK 97909440T DK 0952835 T3 DK0952835 T3 DK 0952835T3
Authority
DK
Denmark
Prior art keywords
heart disease
disease caused
chlamydia pneumoniae
treating heart
treating
Prior art date
Application number
DK97909440T
Other languages
English (en)
Inventor
Sandeep Gupta
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0952835T3 publication Critical patent/DK0952835T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97909440T 1996-10-18 1997-10-17 Fremgangsmåde til behandling af hjertesygdom forårsaget af Chlamydia pneumoniae DK0952835T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2869396P 1996-10-18 1996-10-18
GBGB9621771.6A GB9621771D0 (en) 1996-10-18 1996-10-18 Method of treatment of heart disease
PCT/GB1997/002862 WO1998017280A1 (en) 1996-10-18 1997-10-17 Method of treatment of heart disease caused by chlamydia pneumoniae

Publications (1)

Publication Number Publication Date
DK0952835T3 true DK0952835T3 (da) 2004-08-02

Family

ID=26310252

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97909440T DK0952835T3 (da) 1996-10-18 1997-10-17 Fremgangsmåde til behandling af hjertesygdom forårsaget af Chlamydia pneumoniae

Country Status (13)

Country Link
US (1) US6281199B1 (da)
EP (1) EP0952835B1 (da)
JP (1) JP3580829B2 (da)
AT (1) ATE262910T1 (da)
AU (1) AU736983B2 (da)
CA (1) CA2269054C (da)
DE (1) DE69728420T2 (da)
DK (1) DK0952835T3 (da)
ES (1) ES2218665T3 (da)
GB (1) GB9621771D0 (da)
NZ (1) NZ335825A (da)
PT (1) PT952835E (da)
WO (1) WO1998017280A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
FR2791436B1 (fr) * 1999-03-23 2001-06-15 Inst Nat Sante Rech Med Methode de determination d'une predisposition a une maladie tromboembolique veineuse et utilisation d'agents actifs sur les chlamydia pour la prevention et/ou le traitement de cette maladie
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
IL133038A0 (en) * 1999-11-18 2001-03-19 Savyon Diagnostics Ltd Novel diagnosis and treatment for atherosclerosis
KR20010069066A (ko) 2000-01-12 2001-07-23 이종원 저산소 농도하에서 생존이 가능하도록 하는 동물세포의배양방법
US6914051B1 (en) * 2000-06-28 2005-07-05 David M Allen Penetrating antibiotic gel for soft tissue diseases
US7335638B2 (en) * 2000-07-03 2008-02-26 Maria De Lourdes Higuchi Prevention and treatment of mycoplasma-associated diseases
CA2383850C (en) * 2000-07-03 2012-02-07 Maria De Lourdes Higuchi Prevention and treatment of mycoplasma-associated diseases
US7419657B2 (en) * 2001-08-22 2008-09-02 Cambridge Theranostics Ltd. Treatment of atherosclerotic disorders
AU2003265241A1 (en) * 2002-05-23 2003-12-12 Activbiotics, Inc. Methods of treating bacterial infections and diseases associated therewith
US20040077533A1 (en) * 2002-05-23 2004-04-22 Sayada Chalom B. Methods and compositions for treating bacterial infections and diseases associated therewith
US20090149453A1 (en) * 2002-05-23 2009-06-11 Activbiotics Pharma Llc Methods and compositions for treating bacterial infections and diseases associated therewith
WO2004009084A1 (en) * 2002-07-18 2004-01-29 Pfizer Products Inc. Methods of treating infection using antibiotics and glycogen phosphorylase inhibitors
WO2004054513A2 (en) * 2002-12-12 2004-07-01 Activbiotics, Inc. Methods and compositions for treating and preventing ear infections
EP1575567A4 (en) * 2002-12-12 2008-10-08 Activbiotics Inc METHOD AND REAGENTS FOR TREATING OR PREVENTING ATHEROSCLEROSIS AND DISEASES ASSOCIATED WITH IT
US7674832B2 (en) * 2003-03-28 2010-03-09 Higuchi Maria De Lourdes Compositions for promoting wound healing and treating psoriasis
US8822232B2 (en) 2003-03-28 2014-09-02 Maria De Lourdes Higuchi Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation
BRPI1004987A2 (pt) 2010-11-26 2013-03-26 Maria De Lourdes Higuchi prevenÇço e tratamento de doenÇas associadas as micoplasma
US7732410B2 (en) * 2003-03-28 2010-06-08 Higuchi Maria De Lourdes Compositions for inhibiting atherosclerosis
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency １４員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
AU2013363571A1 (en) * 2012-12-17 2015-07-16 Cormatrix Cardiovascular, Inc. Intra-myocardial agent delivery device, system and method
US11660269B2 (en) * 2019-03-29 2023-05-30 University Of Kentucky Research Foundation Liposomal compounds and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427782A (en) 1981-03-03 1984-01-24 Caldwell Harlan D Isolation of principal outer membrane protein and antigen of Chlamydia trachomatis
DE3650571T2 (de) 1985-01-14 1997-02-27 Chiron Corp Hauptprotein der Aussenmembran von Chlamydia
FI883067A (fi) 1988-06-27 1989-12-28 Labsystems Oy Foerfarande foer behandling av koronarkaerlsjukdom.
WO1992022819A1 (en) * 1991-06-14 1992-12-23 Board Of Regents Of The University Of Washington Diagnosis and treatment of arterial chlamydial granuloma

Also Published As

Publication number Publication date
NZ335825A (en) 2001-01-26
JP2002508738A (ja) 2002-03-19
PT952835E (pt) 2004-08-31
CA2269054C (en) 2005-05-03
AU736983B2 (en) 2001-08-09
US6281199B1 (en) 2001-08-28
DE69728420D1 (de) 2004-05-06
CA2269054A1 (en) 1998-04-30
AU4712697A (en) 1998-05-15
DE69728420T2 (de) 2004-12-30
ES2218665T3 (es) 2004-11-16
ATE262910T1 (de) 2004-04-15
GB9621771D0 (en) 1996-12-11
WO1998017280A1 (en) 1998-04-30
EP0952835B1 (en) 2004-03-31
JP3580829B2 (ja) 2004-10-27
EP0952835A1 (en) 1999-11-03

Similar Documents

Publication Publication Date Title
DK0952835T3 (da) Fremgangsmåde til behandling af hjertesygdom forårsaget af Chlamydia pneumoniae
TR199900083T2 (xx) Klaritromisinin kristal bi�imi I.
EA199901016A1 (ru) 9-оксим-производные эритромицина
FR2651625B1 (fr) Systeme de telecommunications par paquets.
WO2003004509A3 (en) C12 modified erythromycin macrolides and ketolides having antibacterial activity
DE69330294T2 (de) Inter-hierarchisches Synchronisationssystem und LSI, das dieses System verwendet
FR2710873B1 (fr) Système de synchronisation de jonctions.
UY23617A1 (es) Procedimiento para la preparación de derivados de antibióticos macrólidos de anillos de 16 miembros.-
BG104340A (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
BR0101090A (pt) Composição para administração parenteral, e, método para prevenção ou tratamento de infecções ou infestações por helmintos, acarìdeos ou artrópodo endo- ou ectoparasìticos em um animal de sangue quente
IT1285854B1 (it) Gruppo di albero di guida per stampante.
FI944014A (fi) Makrolidien desosaminojohdannaiset immuunivastetta heikentävinä aineina ja sieniä vastustavina aineina
DK1007530T3 (da) 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf
DE69923835D1 (de) Makrolid-lhrh-antagonisten
NO20016221L (no) Difosfatsalt av et 4"-substituert-9-deokso-9A-aza-9A- homoerytromycinderivat og farmasöytisk preparat derav
BR9710537B1 (pt) derivados da eritromicina, composições farmacêuticas, bem como processo para preparação dos mesmos.
TR199802452T2 (xx) Potasyum klavulanat�n preparasyonu i�in geli�tirilmi� bir proses.
OA09447A (fr) Nouveaux dérivés macrolides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2685209B1 (fr) Systeme de connexion sterile.
FR2684508B1 (fr) Systeme de telecommunications par arteres telephoniques offrant des procedures d'acces accelerees, et procede associe.
MX9803694A (es) Derivados de 3-desoxi-3-desclandinosa de eritromicinas a y b.
ES1031313Y (es) Chaveta perfeccionada, para dientes de maquinas para movimiento de tierras.
DE69912959D1 (de) Eythromycinderivat mit antibiotischer aktvität
NO950143L (no) Derivater av antibiotiske makrolider med 16-leddet ring
FR2707088B1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.